Dantrolene prevents arrhythmogenic Ca 2+ release in heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 4, 2012, Pages

  Maxwell, Joshua T ^a   Domeier, Timothy L ^a   Blatter, Lothar A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arrhythmogenesis; Calcium waves; Excitation contraction coupling; Ryanodine receptor

Indexed keywords

CALCIUM; DANTROLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE; INOTROPISM; LOSS OF FUNCTION MUTATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM; CELLS, CULTURED; DANTROLENE; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART VENTRICLES; MUSCLE RELAXANTS, CENTRAL; MYOCYTES, CARDIAC; RABBITS; SARCOPLASMIC RETICULUM;

EID: 84857008274     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00936.2011     Document Type: Article

References (53)

1. 2+ leak in heart failure. Circ Res 97: 1314-1322, 2005.
2. 2+ release channel complex. J Biol Chem 264: 1329-1335, 1989.
3. Bassani JW, Yuan W, Bers DM. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol Cell Physiol 268: C1313-C1319, 1995.
4. Bassani RA, Bers DM. Rate of diastolic Ca release from the sarcoplasmic reticulum of intact rabbit and rat ventricular myocytes. Biophys J 68: 2015-2022, 1995.
5. Belevych A, Kubalova Z, Terentyev D, Hamlin RL, Carnes CA, Gyorke S. Enhanced ryanodine receptor-mediated calcium leak determines reduced sarcoplasmic reticulum calcium content in chronic canine heart failure. Biophys J 93: 4083-4092, 2007.
6. Belevych AE, Terentyev D, Terentyeva R, Nishijima Y, Sridhar A, Hamlin RL, Carnes CA, Gyorke S. The relationship between arrhyth-mogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc Res 90: 493-502, 2011.
7. Bers DM. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda) 21: 380-387, 2006.
8. + in normal and failing cardiac myocytes. Ann NY Acad Sci 1080: 165-177, 2006.
9. Bers DM, MacLeod KT. Cumulative depletions of extracellular calcium in rabbit ventricular muscle monitored with calcium-selective microelec-trodes. Circ Res 58: 769-782, 1986.
10. Cheng H, Lederer WJ, Cannell MB. Calcium sparks: elementary events underlying excitation-contraction coupling in heart muscle. Science 262: 740-744, 1993.
11. + concentration is elevated in heart failure but Na/K pump function is unchanged. Circulation 105: 2543-2548, 2002.
12. 2+, and ATP. Am J Physiol Cell Physiol 294: C1103-C1112, 2008.
13. 2+ release termination by ryanodine receptor sensitization and in heart failure. J Physiol 587: 5197-5209, 2009.
14. Domeier TL, Blatter LA, Zima AV. Changes in intra-luminal calcium during spontaneous calcium waves following sensitization of ryanodine receptor channels. Channels (Austin) 4: 87-92, 2010.
15. Ellis KO, Castellion AW, Honkomp LJ, Wessels FL, Carpenter JE, Halliday RP. Dantrolene, a direct acting skeletal muscle relaxant. J Pharm Sci 62: 948-951, 1973.
16. Fill M, Copello JA. Ryanodine receptor calcium release channels. Physiol Rev 82: 893-922, 2002.
17. Fill M, Coronado R, Mickelson JR, Vilven J, Ma JJ, Jacobson BA, Louis CF. Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J 57: 471-475, 1990.
18. Fill M, Ma JJ, Knudson CM, Imagawa T, Campbell KP, Coronado R. Role of the ryanodine receptor of skeletal muscle in excitation-contraction coupling. Ann NY Acad Sci 560: 155-162, 1989.
19. Fill M, Ramos J. Calcium regulation of single cardiac ryanodine receptor channels. J Muscle Res Cell Motil 25: 603-604, 2004.
20. 2+] and buffering in arrhythmogenic failing rabbit heart. Circ Res 101: 802-810, 2007.
21. Gyorke S, Carnes C. Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease. Pharmacol Ther 119: 340-354, 2008.
22. Kannel WB, Plehn JF, Cupples LA. Cardiac failure and sudden death in the Framingham Study. Am Heart J 115: 869-875, 1988.
23. Kobayashi S, Bannister ML, Gangopadhyay JP, Hamada T, Parness J, Ikemoto N. Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem 280: 6580-6587, 2005.
24. Kobayashi S, Yano M, Suetomi T, Ono M, Tateishi H, Mochizuki M, Xu X, Uchinoumi H, Okuda S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor. J Am Coll Cardiol 53: 1993-2005, 2009.
25. Kobayashi S, Yano M, Uchinoumi H, Suetomi T, Susa T, Ono M Xu X, Tateishi H, Oda T, Okuda S, Doi M, Yamamoto T, Matsuzaki M. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+) knock-in mouse model. Circ J 74: 2579-2584, 2010.
26. Lindner M, Erdmann E, Beuckelmann DJ. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J Mol Cell Cardiol 30: 743-749, 1998.
27. 2+ release channels. Am J Med 104: 470-486, 1998.
28. 2+ waves in rat ventricular myocytes. J Physiol 518: 173-186, 1999.
29. MacLeod KT, Bers DM. Effects of rest duration and ryanodine on changes of extracellular [Ca] in cardiac muscle from rabbits. Am J Physiol Cell Physiol 253: C398-C407, 1987.
30. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosem-blit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376, 2000.
31. 2+ release in heart failure. Cardiovasc Res 87: 609-617, 2010.
32. Paul-Pletzer K, Yamamoto T, Bhat MB, Ma J, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Parness J. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem 277: 34918-34923, 2002.
33. Paul-Pletzer K, Yamamoto T, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Ma J, Parness J. Probing a putative dantrolene-binding site on the cardiac ryanodine receptor. Biochem J 387: 905-909, 2005.
34. Picht E, Zima AV, Blatter LA, Bers DM. SparkMaster: automated calcium spark analysis with ImageJ. Am J Physiol Cell Physiol 293: C1073-C1081, 2007.
35. 2+ content in isolated failing and nonfailing human myocardium. Circ Res 85: 38-46, 1999.
36. Pogwizd SM. Nonreentrant mechanisms underlying spontaneous ventricular arrhythmias in a model of nonischemic heart failure in rabbits. Circulation 92: 1034-1048, 1995.
37. 2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 85: 1009-1019, 1999.
38. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmo-genesis and contractile dysfunction in heart failure: roles of sodium-calcium exchange, inward rectifier potassium current, and residual fj-ad-renergic responsiveness. Circ Res 88: 1159-1167, 2001.
39. 2+ reserve. Circ Res 93: 40-45, 2003.
40. 2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 93: 592-594, 2003.
41. 2+ spark activity and regulation in cat atrial myocytes. J Physiol 572: 799-809, 2006.
42. Smith JS, Imagawa T, Ma J, Fill M, Campbell KP, Coronado R. Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol 92: 1-26, 1988.
43. 2+ content. Cardiovasc Res 90: 503-512, 2011.
44. 2+ leak in chronic heart failure. Circ Res 103: 1466-1472, 2008.
45. 2+ transient amplitude in adult ventricular myocytes. Circ Res 98: 1299-1305, 2006.
46. Venetucci LA, Trafford AW, Eisner DA. Increasing ryanodine receptor open probability alone does not produce arrhythmogenic calcium waves: threshold sarcoplasmic reticulum calcium content is required. Circ Res 100: 105-111, 2007.
47. Wang R, Zhong X, Meng X, Koop A, Tian X, Jones PP, Fruen BR, Wagenknecht T, Liu Z, Chen SR. Localization of the dantrolene binding sequence near the FKBP binding site in the three-dimensional structure of the ryanodine receptor. J Biol Chem 286: 12202-12212, 2011.
48. Ward A, Chaffman MO, Sorkin Dantrolene EM. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs 32: 130-168, 1986.
49. Xu X, Yano M, Uchinoumi H, Hino A, Suetomi T, Ono M, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ikemoto N, Matsuzaki M. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Biochem Biophys Res Commun 394: 660-666, 2010.
50. 2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem 276: 13810-13816, 2001.
51. 2+ leak in normal and failing rabbit ventricular myocytes. J Physiol 588: 4743-4757, 2010.
52. Zima AV, Picht E, Bers DM, Blatter LA. Partial inhibition of sarcoplasmic reticulum Ca release evokes long-lasting Ca release events in ventricular myocytes: role of luminal Ca in termination of ca release. Biophys J 94: 1867-1879, 2008.
53. 2+ diffusion. Circ Res 103: e105-e115, 2008.